Management Team

Webcast

AxoGen Q1 2017 Earnings Call

Listen to the Webcast Replay
Mark Friedman Ph.D.

Mark Friedman Ph.D.

Dr. Friedman joined AxoGen in September 2006. He has served as Vice President of Regulatory Affairs and Quality Assurance for AxoGen, Inc. since November 2011 and AxoGen Corporation since June 2011. Prior to his current role, he served as Director of Quality Assurance and Regulatory Affairs from September 2006 to June 2011 for AxoGen Corporation. Prior to joining AxoGen, Mark held several regulatory and quality leadership positions at Enable Medical Corporation, a medical device company, including Director of Quality Assurance from 1997 to 1998 and Vice President of Quality and Regulatory from 1998 to 2001 and from 2004 to 2005. Mark also worked for AtriCure, Inc., a company that develops, manufactures and sells surgical ablation systems to treat atrial fibrillation, as Vice President of Quality and Regulatory from 2001 to 2004 and as Vice President of Operations in 2004. AtriCure acquired Enable Medical in 2005. Mark has over 24 years of experience in developing and directing regulatory strategy and quality systems for medical products, including 15 years with startup medical product firms. Mark has a Ph.D. in Chemistry specializing in protein biochemistry from the University of Cincinnati.